Long-Acting Injectables for HIV Antiretroviral Therapy
Resource updated 04/12/2024
Resource updated 04/12/2024
Resource updated 10/31/2023
Resource from the RWHAP Best Practices Compilation updated on 06/26/2024
Resource from the RWHAP Best Practices Compilation updated on 01/18/2024
Resource updated 01/29/2024
Resource from the RWHAP Best Practices Compilation updated on 01/08/2024
Resource from the RWHAP Best Practices Compilation updated on 01/12/2024
Resource updated 01/17/2024
Resource updated 04/30/2024
Resource from the RWHAP Best Practices Compilation updated on 06/18/2024
Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
Resource updated 12/07/2023
These charts show improvements in completeness of data reported by Ryan White grantees from 2011 to 2022, measured by known rates for client demographics and clinical information.
Resource updated 09/14/2023
Resource updated 03/13/2024
Resource updated 05/29/2024
Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
Resource from the RWHAP Best Practices Compilation updated on 06/21/2024
Resource from the RWHAP Best Practices Compilation updated on 06/11/2024
Resource from the RWHAP Best Practices Compilation updated on 07/02/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023